• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

healthcare

Indian optician raises $6.4m from AHF, Ventureast

Asia Healthcare Fund (AHF) and early-stage player Ventureast have together invested INR400 million in Eye Gear Optics India, the start-up behind optical retail chain Ben Franklin.

  • Healthcare
  • 04 February 2015
AIF sells India's Famy Care to US-listed Myland for $750m

AIF Capital has sold its stake in Famy Care, an Indian maker of female oral contraceptives, to US-based pharmaceutical firm Mylan Laboratories for $750 million plus contingent payments of up to $50 million.

  • Exits
  • 03 February 2015
CICC funds exit China TCM business as rival agrees $1.3b buyout

Two PE funds managed by China International Capital Corporation (CICC) will exit Jiangyin Tianjiang Pharmaceutical as China Traditional Chinese Medicine (China TCM) buys a majority stake in the business for up to RMB8.34 billion ($1.34 billion).

  • Exits
  • 29 January 2015
Quadria seals landmark Indonesia pharma deal

Southeast Asia-focused healthcare investor Quadria Capital, which is expected to close its latest fund in the next two months, has taken a minority stake in Indonesian drug manufacturer Soho Global Health.

  • Southeast Asia
  • 27 January 2015
Legend Capital leads $100m round for China’s Innovent Biologics

Legend Capital has led a Series C round of funding worth $100 million for Innovent Biologics, a Chinese biopharmaceutical company.

  • Healthcare
  • 27 January 2015
Japan's Mitsui Global backs clinical SaaS start-up

Japan’s Mitsui Global Investment and Dolby Family Ventures have together invested $12 million in cloud-based, clinical study software start-up goBalto.

  • North Asia
  • 22 January 2015
Carlyle-backed Meinian Onehealth invests in rival Ciming Health

Meinian Onehealth Healthcare, China’s largest private provider of healthcare check-up services and a portfolio company of The Carlyle Group, has invested in industry rival Ciming Health Checkup Management Group.

  • Greater China
  • 20 January 2015
Temasek acquires 18% stake in Indian hospital operator

Temasek Holdings - an investment arm of the Singapore government - has acquired a 17.74% stake in Global Health, which operates the Mendanta super specialty hospital in Gurgaon, India.

  • Healthcare
  • 20 January 2015
Australian medical research fund backs antibody start-up

Solvanix, an Australian early-stage biotech company that has developed a technology for improving drug stability, has received A$2 million ($1.6 million) in seed funding from the Medical Research Commercialization Fund (MRCF).

  • Healthcare
  • 19 January 2015
CDC commits $48m to India healthcare provider

UK development finance institution (DFI) CDC Group has invested $48 million in Indian multi-specialty healthcare provider Narayana Hrudayalaya Hospitals (NH) in return for a small minority stake.

  • South Asia
  • 15 January 2015
Yunfeng joins $1.6b deal for China drug maker Baiyunshan

Yunfeng Capital and other investors have agreed to invest up to RMB10 billion ($1.6 billion) in Chinese drug maker Guangzhou Baiyushan Pharmaceutical Holdings.

  • Greater China
  • 14 January 2015
China's BVCF provides $8m round for US biotech firm

China-focused biotech investor BVCF has led an $8 million Series A round of funding for DiaCarta, a US-based firm that develops test kits for detecting cancer.

  • Healthcare
  • 12 January 2015
Ally Bridge leads $25m round for Shanghai Hua Medicine

Ally Bridge Group, a healthcare-focused PE firm, has led a $25 million Series B round of funding for Hua Medicine, a Shanghai-based clinical-stage biotech company.

  • Greater China
  • 09 January 2015
Xeraya, Spruce in $150m first close on second life sciences fund

Khazanah Nasional-controlled Xeraya Capital and Spruce Capital Partners have reached a first close of $150 million on MLS Capital Fund II, successor to the vintage Malaysian Life Sciences Capital Fund, which is now fully allocated.

  • Fundraising
  • 08 January 2015
MSPEA enters the China hospital space

To Homer Sun, CIO at Morgan Stanley Private Equity Asia (MSPEA), the current climate in China’s hospital services space is reminiscent of pharmaceuticals circa 2008. Government policy was pushing the industry towards consolidation and MSPEA capitalized,...

  • Healthcare
  • 07 January 2015
Australian cancer drug developer raises $10m Series B round

Australian biopharmaceutical start-up EnGeneIC has received $10 million in a Series B round of funding led by Boston-based healthcare specialist GRT Capital Partners.

  • Venture
  • 07 January 2015
Chinese insurers win approval for SME-focused PE funds

Chinese insurance companies have been permitted to set up private equity funds that specifically focus on investing in local small and medium-sized enterprises (SMEs).

  • Greater China
  • 02 January 2015
MSPEA, Sihuan Pharma invest in Chinese hospitals - UPDATE

Morgan Stanley Private Equity Asia (MSPEA) has teamed up with Sihuan Pharmaceuticals – one of its portfolio companies – and that company’s chairman to invest RMB1.24 billion ($200 million) in two Chinese hospitals.

  • Healthcare
  • 02 January 2015
Hony, Goldman lead investment in Neusoft medical device units

A consortium including Hony Capital, Goldman Sachs and Canada Pension Plan Investment Board (CPPIB) has agreed to invest $610 million in two medical device subsidiaries owned by Neusoft Corporation, a Chinese IT services provider.

  • Greater China
  • 12 December 2014
Fidelity backs China-based antibody specialist

Two Fidelity funds have participated in a Series A round of funding worth $8 million for Adagene, a China-based life sciences company that specializes in smart antibody technology.

  • Venture
  • 10 December 2014
Japan PE acquires plastics manufacturer, elderly care business

Mid-market GP Japan Private Equity has acquired plastics manufacturer Sekisui Chemicals and care home services business Healthy Service via its third buyout fund.

  • North Asia
  • 09 December 2014
Taiwan’s CDFH, Fujian Electronics in first close on debut RMB fund

Taiwan-based China Development Financial Holding (CDFH) and China’s Fujian Electronics & Information Group have reached a first close of RMB1 billion ($162 million) on their debut renminbi-denominated fund.

  • Greater China
  • 04 December 2014
Qiming leads $10m round for China biopharma player

Qiming Venture Partners has led a $10 million Series A round of funding for CANbridge Life Science, a Beijing-based biopharmaceutical firm.

  • Greater China
  • 03 December 2014
China healthcare: Technology transfer

Healthcare-focused private equity firms want to take technologies from developed markets into China, leveraging rising domestic demand. It is a lucrative strategy, but not necessarily a straightforward one

  • Healthcare
  • 03 December 2014
12 13 14
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013